Dr. Ramakanth Reddy Yakkanti, MD

Dr. Yakkanti practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Yakkanti's NPI, 1679004774, was assigned on March 21, 2017. Dr. Yakkanti graduated from University Of Louisville School Of Medicine in 2017. Dr. Yakkanti holds Florida license ME154674.

Dr. Yakkanti's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Yakkanti's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Yakkanti to 4 more group practices and clinics, 4 medical groups and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yakkanti practices, 7 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Yakkanti's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Yakkanti is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Yakkanti's licenses on file in 3 states: Florida, New Jersey and Pennsylvania.

Dmand AI lists arthritis, hip replacement, joint pain and pelvic and hip fracture among the conditions Dr. Yakkanti treats.

CMS data shows 1,799 Medicare services from Dr. Yakkanti across 17 procedure codes in 2024, for 302 Medicare patients. Medicare paid $103,148 for them.

CMS counts 302 Medicare patients who saw Dr. Yakkanti in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have arthritis, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yakkanti's median patient age at 68, with 59% women.

In 2024, Dr. Yakkanti wrote 242 Medicare Part D claims for 150 patients. 98% of them were for generic drugs. CMS names the drug for 194 of them, across 3 drugs with 11 or more claims each, at $649 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Yakkanti for performance year 2024, reported as part of a group. Dr. Yakkanti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 59 procedures of hip replacement by Dr. Yakkanti, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 47 papers to Dr. Yakkanti, published from 2017 to 2025. 2022 was the busiest year, with 15. The most frequent topics are Arthroplasty, Replacement, Hip, Postoperative Complications and Arthroplasty, Replacement, Knee. Dr. Yakkanti has published most often in J Arthroplasty. Dr. Yakkanti's most frequent co-authors are Amiethab Aiyer, MD, Victor M. Hernandez, MD and Dennis J. Vanden Berge, MD.

Dmand AI links Dr. Yakkanti to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Venous Thromboembolism and Thromboembolism.

CMS Open Payments shows 74 general payments to Dr. Yakkanti from 15 drug and device companies from 2022 to 2025. Education make up the largest share, 43% of the total. Smith & Nephew, Inc. paid the most, $7,366.

Dr. Yakkanti graduated from University Of Louisville School Of Medicine in 2017.

Dr. Yakkanti is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.